ELI LILLY & Co (LLY) operating KPIs
LLYNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 20/3026% above fair value
$1417.54+43.84 (+3.19%)
Close on Oct 30, 2026Market cap $1.33TP/E 46.0Yield 0.44%
Eli Lilly noncurrent operating lease liabilities ($M) ($M)
Form 10-K Leases Note
Latest, FY2025
1,140
Period ended Dec 31, 2025
Change on a year earlier
+17.4%
971 in FY2024
History
5 years
Since FY2018
Sources
4
Documents cited below
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Noncurrent operating lease liabilities ($M) ($M) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 1,140 | +17.4% | Form 10-K (filed 2026-02-12) ↗ |
| FY2024 | Dec 31, 2024 | 971 | +2.4% | Form 10-K (filed 2026-02-12) ↗ |
| FY2023 | Dec 31, 2023 | 949 | – | Form 10-K (filed 2025-02-19) ↗ |
| FY2019 | Dec 31, 2019 | 487 | – | Form 10-K (filed 2020-02-19) ↗ |
| FY2018 | Dec 31, 2018 | 0 | – | Form 10-Q (filed 2019-10-25) ↗ |
Cite this data
StockData. (2026). Eli Lilly Noncurrent operating lease liabilities ($M) ($M), annual FY2018–FY2025 [Data set]. Compiled from Eli Lilly SEC filings and investor materials. https://stockdatahq.com/stocks/lly/kpis/op_lease_liab_nc
See every metric in the Eli Lilly KPI table. Data updated Oct 25, 2026.